NOTICE

This work was made under a CRADA TC02264 by and among GlaxoSmithKline LLC, The Regents of the University of California (solely on behalf of its San Francisco campus), Leidos Biomedical, Inc., the Operations and Technical Support contractor for the Frederick National Laboratory for Cancer Research (an FFRDC in the Department of Health and Human Services), and Lawrence Livermore National Laboratory operated for the United States Department of Energy.  

This work was produced at the Lawrence Livermore National Laboratory (LLNL) under contract no. DE-AC52-07NA27344 (Contract 44) between the U.S. Department of Energy (DOE) and Lawrence Livermore National Security, LLC (LLNS) for the operation of LLNL. Under Contract 44 and CRADA TC02264, copyright is reserved to Lawrence Livermore National Security, LLC and GlaxoSmithKline LLC for purposes of controlled dissemination, commercialization through formal licensing, or other disposition under terms of Contract 44; DOE policies, regulations and orders; and U.S. statutes. The rights of the Federal Government are reserved under Contract 44 and CRADA TC02264. 

This work was prepared as an account of work sponsored by an agency of the United States Government and was created under CRADA TC02264 by GlaxoSmithKline LLC and Lawrence Livermore National Security, LLC. NEITHER THE UNITED STATES GOVERNMENT NOR LAWRENCE LIVERMORE NATIONAL SECURITY, LLC NOR GLAXOSMITHKLINE LLC NOR ANY OF THEIR EMPLOYEES, MAKES ANY WARRANTY, EXPRESS OR IMPLIED, OR ASSUMES ANY LIABILITY OR RESPONSIBILITY FOR THE ACCURACY, COMPLETENESS, OR USEFULNESS OF ANY INFORMATION, APPARATUS, PRODUCT, OR PROCESS DISCLOSED, OR REPRESENTS THAT ITS USE WOULD NOT INFRINGE PRIVATELY-OWNED RIGHTS.  THIS SOFTWARE IS PROVIDED BY LAWRENCE LIVERMORE NATIONAL SECURITY, LLC AND GLAXOSMITHKLINE LLC "AS IS" AND ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT ARE DISCLAIMED. IN NO EVENT SHALL THE COPYRIGHT HOLDERS OR CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES (INCLUDING, BUT NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES; LOSS OF USE, DATA, OR PROFITS; OR BUSINESS INTERRUPTION) HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THIS SOFTWARE, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. 

Reference herein to any specific commercial products, process, or service by trade name, trademark, manufacturer or otherwise does not necessarily constitute or imply its endorsement, recommendation, or favoring by the United States Government, Lawrence Livermore National Security, LLC or GlaxoSmithKline LLC. The views and opinions of authors expressed herein do not necessarily state or reflect those of the United States Government, GlaxoSmithKline LLC or Lawrence Livermore National Security, LLC, and shall not be used for advertising or product endorsement purposes.